These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25120351)

  • 1. Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.
    Coursey TG; de Paiva CS
    Clin Ophthalmol; 2014; 8():1447-58. PubMed ID: 25120351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
    Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
    Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
    Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of dry eye conditions.
    Pflugfelder SC
    Adv Dent Res; 1996 Apr; 10(1):9-12. PubMed ID: 8934916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for anti-inflammatory therapy in dry eye syndrome.
    de Paiva CS; Pflugfelder SC
    Arq Bras Oftalmol; 2008; 71(6 Suppl):89-95. PubMed ID: 19274418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
    Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
    Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
    Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
    Friedlaender MH
    Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
    Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
    J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjögren's syndrome.
    Adatia FA; Michaeli-Cohen A; Naor J; Caffery B; Bookman A; Slomovic A
    Can J Ophthalmol; 2004 Dec; 39(7):767-71. PubMed ID: 15696767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal nerve structure in patients with primary Sjögren's syndrome in China.
    Li F; Zhang Q; Ying X; He J; Jin Y; Xu H; Cheng Y; Zhao M
    BMC Ophthalmol; 2021 May; 21(1):211. PubMed ID: 33980205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
    Stern ME; Gao J; Schwalb TA; Ngo M; Tieu DD; Chan CC; Reis BL; Whitcup SM; Thompson D; Smith JA
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2609-14. PubMed ID: 12147592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmologic Manifestations of Primary Sjögren's Syndrome.
    Roszkowska AM; Oliverio GW; Aragona E; Inferrera L; Severo AA; Alessandrello F; Spinella R; Postorino EI; Aragona P
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33806489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.